Review



cd90  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Miltenyi Biotec cd90
    Cd90, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/TCR+V%CE%B221%2E3+Antibody%2C+anti-human%2C+REAfinity/pm42435424-305-21-23
    Average 93 stars, based on 7 article reviews
    cd90 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Staining:

    Article Title: CD31 + Cell Enrichment Enhances Therapeutic Effects of Stromal Vascular Fraction in Experimental Primary Osteoarthritis: A Preclinical Study in the Dunkin Hartley Guinea Pig Model.
    Article Snippet: The labeled SVF was then placed into a MACSQuant Tyto cartridge (130-104-791, Miltenyi Biotec, Germany), and CD31+ cells were sorted using a MACSQuant Tyto cell sorter (Miltenyi Biotec, Germany). .. The unsorted SVF and sorted CD31+ SVF fractions were stained with fluorophoreconjugated antibodies, including CD31/APC, CD45 (130-110-638, Miltenyi Biotec, Germany) and CD90 (130-114-880, Miltenyi Biotec, Germany). .. Flow cytometric analysis was performed using a CytoFLEX LX Flow Cytometer (Beckman Coulter, US).

    Incubation:

    Article Title: Adipose-derived dual cell therapy enhances arteriogenesis and limb preservation through vascular integration in critical limb ischemia
    Article Snippet: VMSCs and ADSCs were blocked with a human FcR blocking reagent (Miltenyi Biotec), then centrifuged at 500 g at 4 °C for 5 min. .. The cells were incubated with allophycocyanin (APC)-conjugated antibodies against CD29, CD34, CD44, CD45, CD73, CD90, CD105, and CD141 (Miltenyi Biotec). ..

    Article Title: 3D-bioprinted kartogenin-laden hydrogel promotes cartilage regeneration via smad1/5/9-mediated chondrogenesis of bone marrow stromal cells
    Article Snippet: Flow cytometric analysis was performed using a Fortessa flow cytometer (BD Biosciences, USA) to assess BMSC markers. .. After PBS washing, cells were incubated with fluorochrome-conjugated antibodies against CD44, CD90, CD105, CD73, CD146, CD45, CD34, and HLA-DR (Miltenyi Biotec, USA), along with corresponding isotype controls. .. Stained cells were incubated on ice for 30 minutes, washed with MACS buffer (Miltenyi Biotec, USA), and resuspended in the same buffer for analysis.

    other:


    Bioprocessing:

    Article Title: The Use of High-Concentration Collagen-Based Composition and Gelatin Granules as Bioinks for Extrusion 3D Bioprinting of Porous-Structured Hydrogel Constructs
    Article Snippet: 17 ∫ No.5 from the plastic using trypsin solution EDTA (PanEco, Russia) followed by washing the cells free from PBS enzymes (400 g, 5 min) and bringing into test tubes Falcon 12×75 mm (Thermo Fisher Scientific, USA) in amounts of 5·105 cells per 50 μl staining the buffer (PBS with 1% FBS). .. Then there were added murine monoclonal antibodies to CD29, CD90, СD105 (130- 101-27, 130-114-859, 130-112-163; Miltenyi Biotec, Germany); CD44, CD73 (REF 347943, REF 561254; Becton Dickinson, USA); CD45, CD34 (SAB4700480, SAB4700682; Sigma-Aldrich, Germany) in accordance with the manufacturer’s instruction. ..

    Gradient Centrifugation:

    Article Title: Molecular Determinants of the Human Retinal Pigment Epithelium Cell Fate and Potential Pharmacogenomic Targets for Precision Medicine.
    Article Snippet: .. Following density gradient centrifugation of whole blood and retention of PBMCs, immunomagnetic purification of HSCs was performed according to the manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany, CD34 MicroBead Kit UltraPure, human), and cell eluates were assessed by flow cytometry with CD45 (BD PharmingenTM, Milpitas, CA, USA, 560274), CD34 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-120- 520), and CD90 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-117-796). ..

    Purification:

    Article Title: Molecular Determinants of the Human Retinal Pigment Epithelium Cell Fate and Potential Pharmacogenomic Targets for Precision Medicine.
    Article Snippet: .. Following density gradient centrifugation of whole blood and retention of PBMCs, immunomagnetic purification of HSCs was performed according to the manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany, CD34 MicroBead Kit UltraPure, human), and cell eluates were assessed by flow cytometry with CD45 (BD PharmingenTM, Milpitas, CA, USA, 560274), CD34 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-120- 520), and CD90 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-117-796). ..

    Flow Cytometry:

    Article Title: Molecular Determinants of the Human Retinal Pigment Epithelium Cell Fate and Potential Pharmacogenomic Targets for Precision Medicine.
    Article Snippet: .. Following density gradient centrifugation of whole blood and retention of PBMCs, immunomagnetic purification of HSCs was performed according to the manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany, CD34 MicroBead Kit UltraPure, human), and cell eluates were assessed by flow cytometry with CD45 (BD PharmingenTM, Milpitas, CA, USA, 560274), CD34 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-120- 520), and CD90 (Miltenyi Biotec, Bergisch Gladbach, Germany, 130-117-796). ..



    Similar Products

    99
    ATCC human jurkat cd90 cells
    Human Jurkat Cd90 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/Jurkat%2C+Clone+E6-1/us12624338-538-11-15
    Average 99 stars, based on 1 article reviews
    human jurkat cd90 cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd90
    Cd90, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/TCR+V%CE%B221%2E3+Antibody%2C+anti-human%2C+REAfinity/pm42435424-305-21-23
    Average 93 stars, based on 1 article reviews
    cd90 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec cd90 antibody, anti-human, reafinity
    Cd90 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90+Antibody%2C+anti-human%2C+REAfinity/custom%40130-114-901%4041168363
    Average 95 stars, based on 1 article reviews
    cd90 antibody, anti-human, reafinity - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec anti resource source identifier cd90.2 microbeads miltenyi biotec cat
    Anti Resource Source Identifier Cd90.2 Microbeads Miltenyi Biotec Cat, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90%2E2+MicroBeads%2C+mouse/pm42397735-326-2-8
    Average 96 stars, based on 1 article reviews
    anti resource source identifier cd90.2 microbeads miltenyi biotec cat - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec cd44 vioblue
    Cd44 Vioblue, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__06__25__733625-69-23-24
    Average 95 stars, based on 1 article reviews
    cd44 vioblue - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology pe anti mouse cd90 antibody
    Pe Anti Mouse Cd90 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/PE+Anti-Mouse+CD90+Antibody/pmc12907102-324-17-24
    Average 94 stars, based on 1 article reviews
    pe anti mouse cd90 antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec cd90 antibody
    Cd90 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90+Antibody%2C+anti-human/bio_rxiv__64898__2026__05__20__726520-77-7-12
    Average 95 stars, based on 1 article reviews
    cd90 antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec realease cd90 2 microbead kit
    (A–B) C57BL/6J mice were implanted intracranially with a mixture of 5e4 muIL-13Rα2+ CT-2A cells and 5e4 muIL-13Rα2− CT-2A cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. N = 7 per group. (A) Timeline of anti–TNF-α antibody injection. (B) Tumor growth as monitored by bioluminescence imaging. (C) <t>CD90.2+</t> C57BL/6J mice were injected with tumor and CD90.1+ T cells as described in Fig. 2A and sacrificed two or nine days post ACT. N = 3 per group. CD90.2+ cells isolated from each brain were co-cultured with IL-13Rα2− CT-2A cells at a 1:1 effector-to-target ratio for 44 hours. Activation was assessed by cytokine release using FluoroSpot plate. The assay contained biological triplicates (i.e., 3 mice) per treatment group, with each biological replicate seeded in technical duplicates (i.e., 2 wells per mouse; 6 wells per treatment group). Each dot in the plot represents 1 mouse, with a value equal to the mean number of spots between technical duplicate wells. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. (D) C57BL/6J mice were implanted intracranially with a mixture of 5e3 muIL-13Rα2+ SB28-GKO cells and 5e3 muIL-13Rα2− SB28-GKO cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. Tumor growth as monitored by bioluminescence imaging. N = 10 per group.
    Realease Cd90 2 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/REAlease+CD90%2E2+MicroBead+Kit%2C+mouse/pmc13263108-175-21-26
    Average 94 stars, based on 1 article reviews
    realease cd90 2 microbead kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec anti human cd90 pe vio 770 antibody
    (A–B) C57BL/6J mice were implanted intracranially with a mixture of 5e4 muIL-13Rα2+ CT-2A cells and 5e4 muIL-13Rα2− CT-2A cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. N = 7 per group. (A) Timeline of anti–TNF-α antibody injection. (B) Tumor growth as monitored by bioluminescence imaging. (C) <t>CD90.2+</t> C57BL/6J mice were injected with tumor and CD90.1+ T cells as described in Fig. 2A and sacrificed two or nine days post ACT. N = 3 per group. CD90.2+ cells isolated from each brain were co-cultured with IL-13Rα2− CT-2A cells at a 1:1 effector-to-target ratio for 44 hours. Activation was assessed by cytokine release using FluoroSpot plate. The assay contained biological triplicates (i.e., 3 mice) per treatment group, with each biological replicate seeded in technical duplicates (i.e., 2 wells per mouse; 6 wells per treatment group). Each dot in the plot represents 1 mouse, with a value equal to the mean number of spots between technical duplicate wells. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. (D) C57BL/6J mice were implanted intracranially with a mixture of 5e3 muIL-13Rα2+ SB28-GKO cells and 5e3 muIL-13Rα2− SB28-GKO cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. Tumor growth as monitored by bioluminescence imaging. N = 10 per group.
    Anti Human Cd90 Pe Vio 770 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90+Antibody%2C+anti-human%2C+REAfinity/us12624338-749-6-5
    Average 95 stars, based on 1 article reviews
    anti human cd90 pe vio 770 antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    92
    Miltenyi Biotec miltenyi viogreen cd90 dye
    (A–B) C57BL/6J mice were implanted intracranially with a mixture of 5e4 muIL-13Rα2+ CT-2A cells and 5e4 muIL-13Rα2− CT-2A cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. N = 7 per group. (A) Timeline of anti–TNF-α antibody injection. (B) Tumor growth as monitored by bioluminescence imaging. (C) <t>CD90.2+</t> C57BL/6J mice were injected with tumor and CD90.1+ T cells as described in Fig. 2A and sacrificed two or nine days post ACT. N = 3 per group. CD90.2+ cells isolated from each brain were co-cultured with IL-13Rα2− CT-2A cells at a 1:1 effector-to-target ratio for 44 hours. Activation was assessed by cytokine release using FluoroSpot plate. The assay contained biological triplicates (i.e., 3 mice) per treatment group, with each biological replicate seeded in technical duplicates (i.e., 2 wells per mouse; 6 wells per treatment group). Each dot in the plot represents 1 mouse, with a value equal to the mean number of spots between technical duplicate wells. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. (D) C57BL/6J mice were implanted intracranially with a mixture of 5e3 muIL-13Rα2+ SB28-GKO cells and 5e3 muIL-13Rα2− SB28-GKO cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. Tumor growth as monitored by bioluminescence imaging. N = 10 per group.
    Miltenyi Viogreen Cd90 Dye, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd90/CD90%2E1+Antibody%2C+anti-mouse%2Frat%2C+REAfinity/us12624338-684-4-4
    Average 92 stars, based on 1 article reviews
    miltenyi viogreen cd90 dye - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    (A–B) C57BL/6J mice were implanted intracranially with a mixture of 5e4 muIL-13Rα2+ CT-2A cells and 5e4 muIL-13Rα2− CT-2A cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. N = 7 per group. (A) Timeline of anti–TNF-α antibody injection. (B) Tumor growth as monitored by bioluminescence imaging. (C) CD90.2+ C57BL/6J mice were injected with tumor and CD90.1+ T cells as described in Fig. 2A and sacrificed two or nine days post ACT. N = 3 per group. CD90.2+ cells isolated from each brain were co-cultured with IL-13Rα2− CT-2A cells at a 1:1 effector-to-target ratio for 44 hours. Activation was assessed by cytokine release using FluoroSpot plate. The assay contained biological triplicates (i.e., 3 mice) per treatment group, with each biological replicate seeded in technical duplicates (i.e., 2 wells per mouse; 6 wells per treatment group). Each dot in the plot represents 1 mouse, with a value equal to the mean number of spots between technical duplicate wells. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. (D) C57BL/6J mice were implanted intracranially with a mixture of 5e3 muIL-13Rα2+ SB28-GKO cells and 5e3 muIL-13Rα2− SB28-GKO cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. Tumor growth as monitored by bioluminescence imaging. N = 10 per group.

    Journal: Cancer research

    Article Title: Armored Chimeric Antigen Receptor-T Cell Therapy Targets Antigen-Heterogeneous Glioma

    doi: 10.1158/0008-5472.CAN-26-1515

    Figure Lengend Snippet: (A–B) C57BL/6J mice were implanted intracranially with a mixture of 5e4 muIL-13Rα2+ CT-2A cells and 5e4 muIL-13Rα2− CT-2A cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. N = 7 per group. (A) Timeline of anti–TNF-α antibody injection. (B) Tumor growth as monitored by bioluminescence imaging. (C) CD90.2+ C57BL/6J mice were injected with tumor and CD90.1+ T cells as described in Fig. 2A and sacrificed two or nine days post ACT. N = 3 per group. CD90.2+ cells isolated from each brain were co-cultured with IL-13Rα2− CT-2A cells at a 1:1 effector-to-target ratio for 44 hours. Activation was assessed by cytokine release using FluoroSpot plate. The assay contained biological triplicates (i.e., 3 mice) per treatment group, with each biological replicate seeded in technical duplicates (i.e., 2 wells per mouse; 6 wells per treatment group). Each dot in the plot represents 1 mouse, with a value equal to the mean number of spots between technical duplicate wells. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. (D) C57BL/6J mice were implanted intracranially with a mixture of 5e3 muIL-13Rα2+ SB28-GKO cells and 5e3 muIL-13Rα2− SB28-GKO cells. Six days later, mice were injected intratumorally with 5e5 CAR+ murine T cells per mouse. Tumor growth as monitored by bioluminescence imaging. N = 10 per group.

    Article Snippet: Subsequently, red blood cells were lysed using Miltenyi 1x Red Blood Cell Lysis solution, and T cells were enriched with a REAlease ® CD90.2 MicroBead Kit (Miltenyi, Cat# 130-126-706).

    Techniques: Injection, Imaging, Isolation, Cell Culture, Activation Assay